BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1254 related articles for article (PubMed ID: 33469841)

  • 1. Hypoxia-inducible miR-196a modulates glioblastoma cell proliferation and migration through complex regulation of NRAS.
    Takkar S; Sharma V; Ghosh S; Suri A; Sarkar C; Kulshreshtha R
    Cell Oncol (Dordr); 2021 Apr; 44(2):433-451. PubMed ID: 33469841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxic signature of microRNAs in glioblastoma: insights from small RNA deep sequencing.
    Agrawal R; Pandey P; Jha P; Dwivedi V; Sarkar C; Kulshreshtha R
    BMC Genomics; 2014 Aug; 15(1):686. PubMed ID: 25129238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of melatonin in angio-miR-associated inhibition of tumorigenesis and invasion in human glioblastoma tumour spheroids.
    Doğanlar O; Doğanlar ZB; Delen E; Doğan A
    Tissue Cell; 2021 Dec; 73():101617. PubMed ID: 34418770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-196a exerts its oncogenic effect in glioblastoma multiforme by inhibition of IκBα both in vitro and in vivo.
    Yang G; Han D; Chen X; Zhang D; Wang L; Shi C; Zhang W; Li C; Chen X; Liu H; Zhang D; Kang J; Peng F; Liu Z; Qi J; Gao X; Ai J; Shi C; Zhao S
    Neuro Oncol; 2014 May; 16(5):652-61. PubMed ID: 24463357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.
    Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y
    J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mir-370-3p Impairs Glioblastoma Stem-Like Cell Malignancy Regulating a Complex Interplay between HMGA2/HIF1A and the Oncogenic Long Non-Coding RNA (lncRNA) NEAT1.
    Lulli V; Buccarelli M; Ilari R; Castellani G; De Dominicis C; Di Giamberardino A; D Alessandris QG; Giannetti S; Martini M; Stumpo V; Boe A; De Luca G; Biffoni M; Marziali G; Pallini R; Ricci-Vitiani L
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia-mediated mitochondria apoptosis inhibition induces temozolomide treatment resistance through miR-26a/Bad/Bax axis.
    Ge X; Pan MH; Wang L; Li W; Jiang C; He J; Abouzid K; Liu LZ; Shi Z; Jiang BH
    Cell Death Dis; 2018 Nov; 9(11):1128. PubMed ID: 30425242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-449a exerts tumor-suppressive functions in human glioblastoma by targeting Myc-associated zinc-finger protein.
    Yao Y; Ma J; Xue Y; Wang P; Li Z; Li Z; Hu Y; Shang X; Liu Y
    Mol Oncol; 2015 Mar; 9(3):640-56. PubMed ID: 25487955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA (lncRNA) HOXD-AS2 promotes glioblastoma cell proliferation, migration and invasion by regulating the miR-3681-5p/MALT1 signaling pathway.
    Zhong X; Cai Y
    Bioengineered; 2021 Dec; 12(2):9113-9127. PubMed ID: 34802389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circular RNA circ_0001588 sponges miR-211-5p to facilitate the progression of glioblastoma via up-regulating YY1 expression.
    Wang Q; Zheng D; Li Y; Zhang Y; Sui R; Chen Y; Liang H; Shi J; Pan R; Xu X; Sun D
    J Gene Med; 2021 Oct; 23(10):e3371. PubMed ID: 34105224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 and miR-210 regulated NeuroD2, a neuronal basic helix-loop-helix transcription factor, is downregulated in glioblastoma patients and functions as a tumor suppressor under hypoxic microenvironment.
    Agrawal R; Garg A; Benny Malgulwar P; Sharma V; Sarkar C; Kulshreshtha R
    Int J Cancer; 2018 May; 142(9):1817-1828. PubMed ID: 29226333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The miR155HG/miR-185/ANXA2 loop contributes to glioblastoma growth and progression.
    Wu W; Yu T; Wu Y; Tian W; Zhang J; Wang Y
    J Exp Clin Cancer Res; 2019 Mar; 38(1):133. PubMed ID: 30898167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HCMV-encoded miR-UL112-3p promotes glioblastoma progression via tumour suppressor candidate 3.
    Liang Q; Wang K; Wang B; Cai Q
    Sci Rep; 2017 Mar; 7():44705. PubMed ID: 28303930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-200c downregulates HIF-1α and inhibits migration of lung cancer cells.
    Byun Y; Choi YC; Jeong Y; Lee G; Yoon S; Jeong Y; Yoon J; Baek K
    Cell Mol Biol Lett; 2019; 24():28. PubMed ID: 31061665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-129-5p targets Wnt5a to block PKC/ERK/NF-κB and JNK pathways in glioblastoma.
    Zeng A; Yin J; Li Y; Li R; Wang Z; Zhou X; Jin X; Shen F; Yan W; You Y
    Cell Death Dis; 2018 Mar; 9(3):394. PubMed ID: 29531296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA GAPLINC promotes the growth and metastasis of glioblastoma by sponging miR-331-3p.
    Chen HH; Zong J; Wang SJ
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):262-270. PubMed ID: 30657584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miRNA-448 Regulates the Development of Glioblastoma (GBM) by Regulating Rho-Associated Protein Kinase 1.
    Liu C; Zhu B; Zhong M; Bao J
    Comput Math Methods Med; 2022; 2022():2502010. PubMed ID: 35281946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-340 predicts glioblastoma survival and modulates key cancer hallmarks through down-regulation of NRAS.
    Fiore D; Donnarumma E; Roscigno G; Iaboni M; Russo V; Affinito A; Adamo A; De Martino F; Quintavalle C; Romano G; Greco A; Soini Y; Brunetti A; Croce CM; Condorelli G
    Oncotarget; 2016 Apr; 7(15):19531-47. PubMed ID: 26799668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-663 Suppresses Oncogenic Function of CXCR4 in Glioblastoma.
    Shi Y; Chen C; Yu SZ; Liu Q; Rao J; Zhang HR; Xiao HL; Fu TW; Long H; He ZC; Zhou K; Yao XH; Cui YH; Zhang X; Ping YF; Bian XW
    Clin Cancer Res; 2015 Sep; 21(17):4004-13. PubMed ID: 26023083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The genotypic and phenotypic impact of hypoxia microenvironment on glioblastoma cell lines.
    Macharia LW; Muriithi W; Heming CP; Nyaga DK; Aran V; Mureithi MW; Ferrer VP; Pane A; Filho PN; Moura-Neto V
    BMC Cancer; 2021 Nov; 21(1):1248. PubMed ID: 34798868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 63.